Pleural Dynamics Reports Positive Data for Automatic Effusion Shunt
Pleural Dynamics announced positive results from a prospective, multicenter study evaluating its ACES device.
The ACES (automatic continuous effusion shunt) device, developed by Plymouth, Minnesota-based Pleural Dynamics, treats chronic pleural effusions.
It is described as the first and only fully implantable automatic effusion shunt that uses the motion of normal breathing to remove fluid from the chest, offering continuous symptom relief.
- No extended hospital stay required
- No catheter external to the chest needed
- No expensive drainage canisters required
The device addresses the shortcomings of current standards for care in treating pleural effusion, according to the company.
Its one-piece, fully implanted system offers a minimally invasive option for a short hospital stay.
The device offers continuous symptom relief without requiring an extended hospital stay, a catheter external to the chest or expensive drainage canisters.
Author's summary: Pleural Dynamics' ACES device shows positive results.
More News
- Women’s Big Bash League 2025-26 results
- Hundreds stranded after IndiGo canceled 1,000 flights in India air travel chaos
- Babar Azam, Mohammad Rizwan in focus: PCB clears Big Bash NOCs for Pakistan players, but with a catch
- Sydney Sixers Vs Adelaide Strikers, WBBL 2025: SYS-W Beat AS-W By One Run Thanks To Ellyse Perry Century
- Benin authorities say coup attempt foiled, President Talon safe
- Après la tentative de coup d'Etat au Bénin, la menace du pouvoir kaki plus présente que jamais en Afrique
- Flight Booking, Cheap Flights, Air Tickets at Lowest Fare
- GRIDLOCK Definition & Meaning
- Tunbridge Wells gridlocked as residents queue for fresh water after five-day outage
- IndiGo Flights Cancellation Live Updates